The Effect of Ethinylestradiol (EE)/Cyproterone Acetate (CA) and EE/CA Plus Metformin Treatment on Adhesion Molecules in Cases with Polycystic Ovary Syndrome (PCOS)-Reference-Cited by-同舟云学术

The Effect of Ethinylestradiol (EE)/Cyproterone Acetate (CA) and EE/CA Plus Metformin Treatment on Adhesion Molecules in Cases with Polycystic Ovary Syndrome (PCOS)

Published:2009 Issue:14 Volume:48 Page:1193-1199
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Bilgir Oktay¹,Kebapcilar Levent²,Taner Cuneyt³,Bilgir Ferda⁴,Kebapcilar Ayse³,Bozkaya Giray⁵,Yildiz Yasar⁶,Yuksel Arif⁶,Sari Ismail⁶

Affiliation:

1. Internal Medicine Division of Hematology, Bozyaka Training and Research Hospital

2. Internal Medicine, Division of Endocrinology and Metabolism, Bozyaka Training and Research Hospital

3. Gynecology and Obstetric, Izmir Tepecik Gynecology and Obstetrics Research and Training Hospital

4. Internal Medicine, Buca State Hospital

5. Biochemistry, Bozyaka Training and Research Hospital

6. Internal Medicine, Bozyaka Training and Research Hospital

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/48/14/48_14_1193/_pdf

Reference33 articles.

1. 1. Alexander RW. Inflamation and coronary artery disease. N Eng J Med 331: 468-469, 1994.

2. 2. Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159: 1104-1109, 1999.

3. 3. Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women. Am J Epidemiol 154: 758-764, 2001.

4. 4. Paradisi G, Steinberg HO, Hempfling A, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103: 1405-1410, 2001.

5. 5. Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 92: 2944-2951, 2007.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis;The Journal of Clinical Endocrinology & Metabolism;2023-08-09

2. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta‐analysis and systematic review of randomized controlled trials;Clinical Endocrinology;2023-04-07

3. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women;BMC Women's Health;2023-02-15

4. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials;Archives of Gynecology and Obstetrics;2022-04-18

5. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials;PLOS ONE;2021-07-19